A CRA expert testified at trial regarding the amount of reasonable royalties due to a spine surgeon as a result of the infringement of his patents by a major medical device company. The expert relied on a survey of surgeons to determine how frequently they performed the patented technique using the defendant’s surgical instruments. She evaluated the economic and technological comparability of a license agreements, the feasibility of non-infringing alternatives, and the Georgia-Pacific factors to determine the appropriate reasonable royalty rate. The jury awarded an 8-figure damages award based on the CRA expert’s testimony. The verdict was upheld on appeal.
CRA consultants recognized among leading IP professionals in the 2025 IAM Strategy 300
Daniel McGavock, Robert Goldman, and Dr. Richard Razgaitis were recognized as leading IP strategists by Intellectual Asset Management (IAM) in the latest...